Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Romana Netea-Maier"'
Autor:
Jaume Capdevila, Desiree’ Deandreis, Cosimo Durante, Sophie Leboulleux, Markus Luster, Romana Netea-Maier, Kate Newbold, Susanne Singer, Gerasimos P Sykiotis, Beate Bartes, Kate Farnell, Laura Deborah Locati
Publikováno v:
European Thyroid Journal, Vol 12, Iss 5, Pp 1-11 (2023)
Background: Most thyroid cancers of follicular origin have a favorable outcome. Only a small percentage of patients will develop metastatic disease, some of which will become radioiodine refractory (RAI-R). Important challenges to ensure the best the
Externí odkaz:
https://doaj.org/article/5c1a0363053d485dba6e240cc1b2c257
Autor:
Floortje Mols, Dounya Schoormans, Romana Netea-Maier, Olga Husson, Sandra Beijer, Katrijn Van Deun, Wouter Zandee, Marleen Kars, Pleun C. M. Wouters van Poppel, Suat Simsek, Patrick van Battum, Jérôme M. H. Kisters, Jan Paul de Boer, Elske Massolt, Rachel van Leeuwaarde, Wilma Oranje, Sean Roerink, Mechteld Vermeulen, Lonneke van de Poll-Franse
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-9 (2023)
Abstract Background Thyroid cancer (TC) patients are understudied but appear to be at risk for poor physical and psychosocial outcomes. Knowledge of the course and determinants of these deteriorated outcomes is lacking. Furthermore, little is known a
Externí odkaz:
https://doaj.org/article/999313e7c3b8487d9e71c189727430cd
Autor:
Anna Koot, Rosella Hermens, Petronella Ottevanger, Romana Netea-Maier, Peep Stalmeier, the COMBO study group, Marieke Snel, Noortje van der Kleij-Corssmit, Johannes Bonenkamp, Koen Dreijerink, Evelien van Dam, Grard Nieuwenhuijzen, Mariel Keemers, Lieke Welling, Iris van der Ploeg, Sanne Engelen, Danielle Dercks, Frans Geenen
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundPatient decision aids (PtDAs) are structured clinical tools that facilitate shared decision-making. Two important treatment decisions for patients with differentiated thyroid cancer (DTC), which could benefit from PtDAs, are as follows (1):
Externí odkaz:
https://doaj.org/article/fe514fc99b114bbb8f803ccac5c1afb8
Autor:
Thomas Crezee, Mirela Petrulea, Doina Piciu, Martin Jaeger, Jan W A Smit, Theo S Plantinga, Carmen E Georgescu, Romana Netea-Maier
Publikováno v:
Endocrine Connections, Vol 9, Iss 11, Pp 1065-1074 (2020)
The PI3K-Akt-mTOR pathway plays a central role in the development of non-medullary thyroid carcinoma (NMTC). Although somatic mutations have been identified in these genes in NMTC patients, the role of germline variants has not been investigated. Her
Externí odkaz:
https://doaj.org/article/2f4a2973c0034a74bac515cff6fe505f
Autor:
Pepijn van Houten, Jacky de Rooy, Ingrid van der Geest, Romana Netea-Maier, Annenienke van de Ven
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100756- (2021)
Avascular necrosis of the femoral head is a well-known complication of treatment with high dosage glucocorticoids and has been described in a few patients with Cushing's syndrome. In this case report, we describe the, to our knowledge, first case of
Externí odkaz:
https://doaj.org/article/e47a943646b74521a6f59f9e36a6e702
Autor:
Marc Eissing, Lise Ripken, Gerty Schreibelt, Harm Westdorp, Marjolijn Ligtenberg, Romana Netea-Maier, Mihai G. Netea, I. Jolanda M. de Vries, Nicoline Hoogerbrugge
Publikováno v:
Translational Oncology, Vol 12, Iss 2, Pp 361-367 (2019)
Carriers of a pathogenic germline mutations in the PTEN gene, a well-known tumor suppressor gene, are at increased risk of multiple benign and malignant tumors, e.g. breast, thyroid, endometrial and colon cancer. This is called PTEN Hamartomous Tumor
Externí odkaz:
https://doaj.org/article/8405faa66c6646a08f611ea794e52c69
Autor:
Andreea-Ioana Stefan, Andra Piciu, Maria Margareta Cosnarovici, Monica Dragomir, Romana Netea-Maier, Doina Piciu
Publikováno v:
Children, Vol 8, Iss 5, p 422 (2021)
Thyroid microcarcinoma in pediatric population in Romania Non-medullary thyroid cancer (TC) is the most common endocrine malignancy, with an increasing incidence in the recent years, due to the increase of the thyroid microcarcinoma. Thyroid microcar
Externí odkaz:
https://doaj.org/article/b0b432ed9ec3450890e27abd154c33fc
Autor:
Laura D. Locati, Elena Colombo, Marek Dedecjus, Christelle de la Fouchardière, Ward Sents, Massimo Bongiovanni, Romana Netea-Maier
Publikováno v:
European Journal of Cancer, 180, 146-154
European Journal of Cancer, 180, pp. 146-154
European Journal of Cancer, 180, pp. 146-154
Anaplastic thyroid carcinoma (ATC) is a rare cancer accounting for 40% of thyroid cancer-specific deaths. In the last 5 years, improved insights into molecular pathways led the Food and Drug Administration to license BRAF/MEK inhibitors (B/Mi) in BRA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd471bb28f23273aa1335010c6fe51e6
http://hdl.handle.net/2066/289460
http://hdl.handle.net/2066/289460
Autor:
Anna Koot, Paula Soares, Eyal Robenshtok, Laura D. Locati, Christelle de la Fouchardiere, Markus Luster, Massimo Bongiovanni, Rosella Hermens, Petronella Ottevanger, Frans Geenen, Beate Bartѐs, Harald Rimmele, Cosimo Durante, Els Nieveen-van Dijkum, Peep Stalmeier, Marek Dedecjus, Romana Netea-Maier
Publikováno v:
European Journal of Cancer, 179, 98-112
European Journal of Cancer, 179, 98-112. Elsevier Limited
European Journal of Cancer, 179, pp. 98-112
European Journal of Cancer, 179, 98-112. Elsevier Limited
European Journal of Cancer, 179, pp. 98-112
Contains fulltext : 287669.pdf (Publisher’s version ) (Open Access) The incidence of differentiated thyroid cancer (DTC) has been increasing worldwide, mostly, as an increase in the incidental detection of micro papillary thyroid carcinomas (microP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017934be9a121b4347fef4053025de02
http://hdl.handle.net/2066/287669
http://hdl.handle.net/2066/287669
Autor:
Zeinab M. Mamdouh, Cristian Nogales, Cecili Macchiusi, Mahmoud Elbatreek, Mayra Pacheco Pachado, Michael Hartung, Olga Zolotareva, Sandra Laternser, Jan Baumbach, Sander MJ van Kuijk, Markus List, Javad Nazarian, Romana Netea-Maier, Harald H.H.W. Schmidt
Publikováno v:
Network pharmacology and drug repurposing pave the way for precision oncology.